RAB27B and hepatocellular carcinoma: Similar to the expression results identified in tissues, as a secretory small GTPase, RAB27B was significantly elevated in the serum and plasma of patients with hepatocellular carcinoma, but was lower in patients with chronic hepatitis B and in healthy individuals, indicating that it may be a potential biomarker for early diagnosis and as a therapeutic target in HCC.